Lv2
118 积分 2021-12-23 加入
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
4天前
已完结
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
4天前
已完结
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells
5天前
已完结
Glucocorticoid-induced tumor necrosis factor receptor–related protein co-stimulation facilitates tumor regression by inducing IL-9–producing helper T cells
20天前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
27天前
已完结
MEF2D-expressing cancer precursors reprogram tissue-resident macrophages to support liver tumorigenesis
1个月前
已完结
pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication
1个月前
已完结
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth
1个月前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
